NCT05538091
- Conditions
- Hedgehog Inhibitor, PARP Inhibitor, Platinum-Resistant Fallopian Tube Carcinoma, +1 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Platinum-Resistant Fallopian Tube Carcinoma
Explore clinical trials studying Platinum-Resistant Fallopian Tube Carcinoma. Study availability and eligibility vary by location and protocol.
18 public trials
4 recruiting studies
Platinum-Resistant Fallopian Tube Carcinoma trial results
Recruiting
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
NCT04055649
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +24 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
NCT06730347
- Conditions
- Clear Cell Adenocarcinoma of Cervix, Clear Cell Adenocarcinoma of Fallopian Tube, Clear Cell Adenocarcinoma of Ovary, +20 more
- Locations
-
- UCLA Los Angeles, California, United States
- Ochsner MD Anderson Cancer Center New Orleans, Louisiana, United States
- START Midwest Grand Rapids, Michigan, United States
- West Penn Allegheny Health Pittsburgh, Pennsylvania, United States
NCT06483048
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +30 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
Completed
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
NCT05483933
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
- Locations
-
- University of Arkansas for Medical sciences Little Rock, Arkansas, United States
- City of Hope Duarte, California, United States
- Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
- START Midwest Grand Rapids, Michigan, United States
NCT03026062
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03508570
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +58 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03206047
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT02020707
- Conditions
- Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma, +45 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic High Grade Fallopian Tube Serous Adenocarcinoma, +27 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States